Comparison of one-week versus three-week paclitaxel for advanced pan-carcinomas: systematic review and meta-analysis-Reference-Cited by-同舟云学术

Comparison of one-week versus three-week paclitaxel for advanced pan-carcinomas: systematic review and meta-analysis

Published:2022-02-26 Issue:4 Volume:14 Page:1959-1982
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Lin Shitong¹²,Peng Ting¹²,Meng Yifan³,Cao Canhui⁴,Gao Peipei¹²,Wu Ping¹²,Zhi Wenhua¹²,Wei Ye¹²,Chu Tian¹²,Liu Binghan¹²,Wei Juncheng¹²,Huang Xiaoyuan¹²,Ding Wencheng¹²,Cheng Cai⁵

Affiliation:

1. Cancer Biology Research Center (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

2. Department of Gynecologic Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

3. Department of Gynecologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China

4. Department of Reproductive Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong Province, China

5. Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference57 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.;Bray;CA Cancer J Clin,2021

2. Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.;Postmus;J Clin Oncol,1998

3. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.;Davidson;N Engl J Med,1996

4. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.;Hortobagyi;J Natl Cancer Inst,1991

5. A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study.;Mutch;Gynecol Oncol,1996

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scalp hypothermia to reduce chemotherapy-induced alopecia: A systematic review and meta-analysis;Gynecologic Oncology;2024-09

2. Clinical Efficacy of Taxol Plus Platinum (TP) Chemotherapy Combined with Delayed Administration of PD-1 Inhibitors in Patients with Locally Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma: A Retrospective Study;Drug Design, Development and Therapy;2024-07

3. Effectiveness and safety of standard chemotherapy in older patients with ovarian cancer: a retrospective analysis by age group and treatment regimen;Frontiers in Oncology;2023-12-13

4. Molecular identification and functional characterization of two glycosyltransferases genes from Fallopia multiflora;Frontiers in Plant Science;2022-12-06